Patent · US Expired

Imidazole derivatives

US5179111A · kind A · utility

6Cited by

2References

13Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Helmut Biere · Berlin, DE
Ralph Rohde · Berlin, DE
Herbert Schneider · Berlin, DE
Lechoslaw Turski · Berlin, DE

Key dates

Filing date	Dec 14, 1988
Grant date	Jan 12, 1993
Priority date	—
Expiry date	Dec 14, 2008

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Imidazole derivatives of general Formula I ##STR1## wherein R.sup.1 means hydrogen, an optionally substituted C.sub.1-10 hydrocarbon or hetaryl residue, or a cyclic ether residue, PA0 R.sup.2 means hydrogen, halogen, an optionally substituted amino, nitro, azide, thiocyanate or cyano group, a linear or branched C.sub.1-10 -alkyl residue optionally substituted with halogen, or -OR.sup.1 wherein R.sup.1 has the above-mentioned meanings, and PA0 R.sup.1 and R.sup.2 jointly with the oxygen atom form a saturated or unsaturated 5- to 7-membered ring which can contain still another hetero atom, PA0 R.sup.3 means hydrogen, a linear or branched C.sub.1-6 -alkyl group, or a C.sub.1-6 -alkoxyalkyl group, PA0 R.sup.4 means -COOR.sup.5, -CONR.sup.6 R.sup.7, -CN, ##STR2## and their use as medicinal agents are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.